Vitamin D supplementation to prevent acute respiratory infections.

Vitamin D supplementation to prevent acute respiratory infections.


Health Technol Assess. 2019 01 ;23(2):1-44. PMID: 30675873

Abstract Title: 

Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis.


BACKGROUND: Randomised controlled trials (RCTs) exploring the potential of vitamin D to prevent acute respiratory infections have yielded mixed results. Individual participant data (IPD) meta-analysis has the potential to identify factors that may explain this heterogeneity.OBJECTIVES: To assess the overall effect of vitamin D supplementation on the risk of acute respiratory infections (ARIs) and to identify factors modifying this effect.DATA SOURCES: MEDLINE, EMBASE, the Cochrane Central Register of Controlled Trials (CENTRAL), Web of Science, and the International Standard Randomised Controlled Trials Number (ISRCTN) registry.STUDY SELECTION: Randomised, double-blind, placebo-controlled trials of supplementation with vitamin Dor vitamin Dof any duration having incidence of acute respiratory infection as a prespecified efficacy outcome were selected.STUDY APPRAISAL: Study quality was assessed using the Cochrane Collaboration Risk of Bias tool to assess sequence generation, allocation concealment, blinding of participants, personnel and outcome assessors, completeness of outcome data, evidence of selective outcome reporting and other potential threats to validity.RESULTS: We identified 25 eligible RCTs (a total of 11,321 participants, aged from 0 to 95 years). IPD were obtained for 10,933 out of 11,321 (96.6%) participants. Vitamin D supplementation reduced the risk of ARI among all participants [adjusted odds ratio (aOR) 0.88, 95% confidence interval (CI) 0.81 to 0.96; heterogeneity 

read more



Write a comment


This site uses Akismet to reduce spam. Learn how your comment data is processed.